Latest Regulatory Approvals News

Fitzroy River Corporation reported steady royalty income for the December 2025 quarter, while advancing key projects including a $40 million funding campaign for the Rafael Gas Project and a $150 million equity raise for Snowy River Gold development.

Santana Minerals has cleared key regulatory and operational hurdles for its Bendigo-Ophir Gold Project in New Zealand, with a 30-year mining permit granted and strong drilling results boosting project prospects ahead of targeted mid-2026 construction.

Strata Minerals has secured full ownership of the Zelica Gold Project in WA’s Eastern Goldfields, launched maiden drilling targeting high-grade gold, and expanded the project footprint through a strategic acquisition, supported by a $1.1 million capital raise.

Echo IQ has completed clinical validation of its EchoSolv HF heart failure detection software with the Mayo Clinic Platform, achieving outstanding accuracy. The company has now formally submitted its FDA 510(k) clearance application, positioning itself for significant commercial expansion in the US healthcare market.

Cyprium Metals is advancing its brownfield restart of the Nifty Copper Complex in Western Australia, targeting mid-2026 copper cathode production with a low-capital, high-cash-flow approach. The company has secured $41 million through an institutional placement and entitlement offer to fund exploration and expansion.

Marvel Gold Limited has pinpointed five high priority gold targets at its Hanang Project in Tanzania from initial drone magnetic survey data, setting the stage for a maiden drilling campaign in early 2026.

Impact Minerals has acquired a 55 sq km tenement covering the historic Huonville gold district near Broken Hill, significantly expanding its landholding and advancing its exploration for copper-gold deposits.

Anteris Technologies has completed a $90 million strategic investment from Medtronic as part of a $320 million capital raise, advancing its DurAVR transcatheter heart valve towards global commercialisation and pivotal clinical trials.

Anteris Technologies has closed a $320 million capital raise, combining a $230 million public offering and a strategic private placement with Medtronic, to advance its DurAVR heart valve clinical trials and manufacturing growth.

Light & Wonder, Inc. has amended its credit agreement to introduce a new $2.13 billion tranche of term loans due in 2029, replacing prior debt and reducing borrowing costs. The move reflects a strategic refinancing amid its Nasdaq delisting process.

Rox Resources has confirmed the economic viability of its Youanmi Gold Project with a robust feasibility study and commenced underground mining, backed by a $218 million equity raise. The company is on track for first gold production by mid-2027.

Anteris Technologies Global Corp. has launched a $230 million equity offering alongside an $84 million private placement with Medtronic’s subsidiary, aiming to accelerate clinical trials and scale manufacturing of its innovative DurAVR Transcatheter Heart Valve.